These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8805617)

  • 21. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.
    Rabquer B; Smithson SL; Shriner A; Julie Westerink MA
    Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro B-cell response to pneumococcal polysaccharides in adults and neonates.
    Rijkers GT; Dollekamp EG; Zegers BJ
    Scand J Immunol; 1987 May; 25(5):447-52. PubMed ID: 3495866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-idiotypic antibodies as vaccines against carbohydrate antigens.
    Westerink MA; Apicella MA
    Springer Semin Immunopathol; 1993; 15(2-3):227-34. PubMed ID: 8256200
    [No Abstract]   [Full Text] [Related]  

  • 24. [Production of monoclonal antibodies to T-independent type 2 antigens with OptiMem-Iscove medium].
    Sidorova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (4):41-3. PubMed ID: 11569260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired IgM Memory B Cell Function Is Common in Coeliac Disease but Conjugate Pneumococcal Vaccination Induces Robust Protective Immunity.
    Moscatelli OG; Russell AK; Henneken LM; Hardy MY; Mazarakis N; Higgins R; Ekin J; McLeod H; Simkin P; Licciardi PV; Bryant VL; Tye-Din JA
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Reductive Amination to Produce Capsular Polysaccharide-Based Glycoconjugates.
    Urbano-Munoz F; Orne CE; Burtnick MN; Brett PJ
    Methods Mol Biol; 2024; 2762():139-148. PubMed ID: 38315364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines.
    Micoli F; Stefanetti G; MacLennan CA
    Front Mol Biosci; 2023; 10():1201693. PubMed ID: 37261327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines.
    Rohokale R; Guo Z
    ACS Infect Dis; 2023 Feb; 9(2):178-212. PubMed ID: 36706246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments.
    Shivatare SS; Shivatare VS; Wong CH
    Chem Rev; 2022 Oct; 122(20):15603-15671. PubMed ID: 36174107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases.
    Stefanetti G; Borriello F; Richichi B; Zanoni I; Lay L
    Front Cell Infect Microbiol; 2021; 11():808005. PubMed ID: 35118012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines.
    Anish C; Beurret M; Poolman J
    NPJ Vaccines; 2021 Dec; 6(1):150. PubMed ID: 34893630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing the Physical Properties and Cell Compatibility of Phytoglycogen Extracted from Different Sweet Corn Varieties.
    Liu R; Boehlein SK; Tracy WF; Resende MFR; Hudalla GA
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32024194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses.
    Rhoads JP; Major AS
    Crit Rev Immunol; 2018; 38(4):333-342. PubMed ID: 30806246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering a new generation of carbohydrate-based vaccines.
    Weyant KB; Mills DC; DeLisa MP
    Curr Opin Chem Eng; 2018 Mar; 19():77-85. PubMed ID: 30568873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis.
    Burtnick MN; Shaffer TL; Ross BN; Muruato LA; Sbrana E; DeShazer D; Torres AG; Brett PJ
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29109172
    [No Abstract]   [Full Text] [Related]  

  • 36. Lysibodies are IgG Fc fusions with lysin binding domains targeting
    Raz A; Serrano A; Lawson C; Thaker M; Alston T; Bournazos S; Ravetch JV; Fischetti VA
    Proc Natl Acad Sci U S A; 2017 May; 114(18):4781-4786. PubMed ID: 28428342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies.
    Wu X; Kong XP
    Curr Opin Immunol; 2016 Oct; 42():56-64. PubMed ID: 27289425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against Experimental Melioidosis with a Synthetic manno-Heptopyranose Hexasaccharide Glycoconjugate.
    Scott AE; Christ WJ; George AJ; Stokes MG; Lohman GJ; Guo Y; Jones M; Titball RW; Atkins TP; Campbell AS; Prior JL
    Bioconjug Chem; 2016 Jun; 27(6):1435-46. PubMed ID: 27124182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.
    Scott AE; Burtnick MN; Stokes MG; Whelan AO; Williamson ED; Atkins TP; Prior JL; Brett PJ
    Infect Immun; 2014 Aug; 82(8):3206-13. PubMed ID: 24866807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dectin-2-dependent NKT cell activation and serotype-specific antibody production in mice immunized with pneumococcal polysaccharide vaccine.
    Miyasaka T; Akahori Y; Toyama M; Miyamura N; Ishii K; Saijo S; Iwakura Y; Kinjo Y; Miyazaki Y; Oishi K; Kawakami K
    PLoS One; 2013; 8(10):e78611. PubMed ID: 24205278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.